Healthcare Executive Collapses During Oval Office Event
Gordon Findlay, a senior executive from Novo Nordisk, fainted Thursday at the Oval Office during an announcement concerning weight loss drugs. The event, hosted by President Donald Trump, was momentarily stopped as medical personnel rushed to assist him.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," said White House Press Secretary Karoline Leavitt. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly."
The announcement focused on a new federal agreement with Eli Lilly and Novo Nordisk to make certain obesity medications available to Americans at approximately $150 for a month’s supply. The incident occurred while Eli Lilly CEO David Ricks was speaking, prompting staff to escort the press from the room. Deputy Press Secretary Kush Desai stated that Dr. Kennedy left to obtain further medical help before the event resumed around 1:29 p.m.
Context of the Event
- Location: Oval Office, Washington
- Date: Thursday (specific date not provided)
- Main participants: President Donald Trump, Dr. Mehmet Oz, Gordon Findlay, and Eli Lilly CEO David Ricks
- Purpose: To announce a partnership aimed at reducing the cost of obesity treatments
Outcome
Findlay is expected to recover fully following the brief medical episode, according to official statements. The press conference continued shortly after with no further incidents.
Author’s summary: A Novo Nordisk executive fainted during President Trump’s Oval Office event on affordable weight loss drugs, prompting a short pause before proceedings resumed.